Results 31 to 40 of about 17,163,674 (412)

In-silico simulated prototype-patients using TPMS technology to study a potential adverse effect of sacubitril and valsartan

open access: yesPLoS ONE, 2020
Unveiling the mechanism of action of a drug is key to understand the benefits and adverse reactions of a medication in an organism. However, in complex diseases such as heart diseases there is not a unique mechanism of action but a wide range of ...
Guillem Jorba   +8 more
semanticscholar   +1 more source

Low-dose amisulpride for debilitating clozapine-induced sialorrhea: Case series and review of literature

open access: yesIndian Journal of Psychological Medicine, 2015
Clozapine-induced sialorrhea (CIS) affects about one-third of patients treated with clozapine, at times can be stigmatizing, socially embarrassing, disabling, affect quality-of-life, cause poor compliance and can be potentially life-threatening adverse ...
Ranganath R Kulkarni
doaj   +1 more source

Galectin-3 as a Therapeutic Target for NSAID-Induced Intestinal Ulcers

open access: yesFrontiers in Immunology, 2020
Non-steroidal anti-inflammatory drugs (NSAIDs) induce ulcers in the gastrointestinal tract, including the stomach and small intestine. NSAID-induced gastric ulcers can be prevented by taking acid-neutralizing/inhibitory drugs and cytoprotective agents ...
Ah-Mee Park   +8 more
doaj   +1 more source

Possible Negative Effects of Psychotherapies [PDF]

open access: yesPsikiyatride Güncel Yaklaşımlar, 2012
Any treatment that has the potential to be useful could also have harmful effects on patients. All psychotherapy approaches should take this issue into consideration. Although there is no direct intervention to the physical integrity of the patient, this
I. Volkan Gulum
doaj  

Safety and Efficacy of Chimeric Antigen Receptor T-Cell Therapy for Glioblastoma: A Systemic Review and Meta-Analysis

open access: yesFrontiers in Oncology, 2022
BackgroundChimeric antigen receptor (CAR) T-cell therapy is a promising treatment option for patients with refractory hematological malignancies. However, its efficacy in glioblastoma remains unclear.
Jong Keon Jang   +6 more
doaj   +1 more source

Case report: A rare case of neutropenia caused by pembrolizumab in squamous lung cancer and literature review

open access: yesFrontiers in Oncology, 2022
BackgroundImmune checkpoint inhibitors, including anti-PD-1 therapies, have prolonged overall survival in patients with a variety of cancers, and immunotherapy is sometimes associated with immune-related adverse events (irAEs); however, hematological ...
Qiaoyun Tan   +4 more
doaj   +1 more source

Adverse Reactions of COVID-19 Vaccines: A Scoping Review of Observational Studies

open access: yesInternational Journal of General Medicine, 2023
Inge Dhamanti,1– 3 Auliya A Suwantika,4– 6 Amirah Adlia,7 Laura Navika Yamani,8,9 Fitri Yakub10 1Department of Health Policy and Administration, Faculty of Public Health, Universitas Airlangga, Surabaya, Indonesia; 2Center for Patient Safety Research ...
Dhamanti I   +4 more
doaj  

Efficacy and Safety of Anlotinib Combined with PD-1 Blockades for Patients with Advanced Epithelial Ovarian Cancer

open access: yesZhongliu Fangzhi Yanjiu, 2022
Objective To investigate the efficacy and safety of anlotinib combined with PD-1 blockades for patients with advanced epithelial ovarian cancer (EOC).
JIN Huimin   +3 more
doaj   +1 more source

Pulmonary thromboembolism associated with quetiapine: a case report

open access: yesPsychiatry and Clinical Psychopharmacology, 2017
Venous Thromboembolism (VTE), which includes pulmonary embolism and deep-vein thrombosis is also a potentially fatal adverse drug reaction and little attention has been focused on this topic.
Demet Sağlam Aykut   +1 more
doaj   +1 more source

Tolerability of Ramipril 10 mg Daily in High-risk Cardiovascular Patients in Taiwan: Experience from Kaohsiung Medical University Chung-Ho Memorial Hospital

open access: yesKaohsiung Journal of Medical Sciences, 2005
The Heart Outcomes Prevention Evaluation (HOPE) study demonstrated that the angiotensin-converting enzyme inhibitor, ramipril, significantly reduces mortality, myocardial infarction and stroke in high-risk cardiovascular patients, beyond the benefits ...
Chih-Sheng Chu   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy